AI Verdict
GILD has stronger fundamentals based on our AI analysis.
ABT vs GILD Fundamental Comparison
| Metric | ABT | GILD |
|---|---|---|
| Revenue | $11.2B | $7.0B |
| Net Income | $1.1B | $2.0B |
| Net Margin | 9.6% | 29.0% |
| ROE | 2.1% | 8.6% |
| ROA | 1.0% | 3.6% |
| Current Ratio | 1.39x | 1.97x |
| Debt/Equity | 0.57x | 0.94x |
| EPS | $0.61 | $1.61 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABT vs GILD: Frequently Asked Questions
Is ABT or GILD the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GILD has stronger fundamentals. ABT is graded B (74% confidence) while GILD is graded A (78% confidence). This is not investment advice.
How does ABT compare to GILD fundamentally?
ABBOTT LABORATORIES has ROE of 2.1% vs GILEAD SCIENCES, INC.'s 8.6%. Net margins are 9.6% vs 29.0% respectively.
Which stock pays higher dividends, ABT or GILD?
ABT has a dividend yield of N/A or no dividend while GILD has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABT or GILD for long term?
For long-term investing, consider that ABT has a B grade with 74% confidence, while GILD has a A grade with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABT vs GILD?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABT vs GILD, the AI consensus favors GILD based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.